According to BlockBeats, Conflux's stock experienced a brief surge of over 10% following news of a potential acquisition by Linghang Pharmaceutical. The two companies have reportedly signed a memorandum of understanding regarding the acquisition of all Conflux shares. After the initial increase, Conflux's stock price settled at $0.0788, raising its market capitalization to $387 million.